Sa-mRNA Influenza (H5N1) Vaccine(Csl)

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameSa-mRNA Influenza (H5N1) Vaccine(Csl)
Drug Alias NameSQ012SQ-012
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCsl Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCsl Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A